Hot Life Science Investor Mandate 2: VC in Eastern US Looking for Biotech R&D for New Allocations – March 28, 2013

25 Mar

A venture capital group based in the Eastern US has around $200 million in assets, and is currently deploying capital from its second fund, which has approximately $150 million in assets. They are currently looking for new investment opportunities in the life sciences space, and plan to invest in 2-3 new firms within the next six to nine months.

The firm allocates $1-10 million per investment, and the majority of its investments are in the $5-10 million range. Currently, the VC is most interested in biotech R&D services firms, and is seeking contract manufacturing organizations (CMOs) and contract research organizations (CROs).

Their primary mandate is for biotech firms whose primary customer base are biotech therapeutic and diagnostic firms, as well as pharmaceutical companies. The firm prefers companies that have at least $2 million in revenue, but prefers firms in the $5-30 million range.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: